Srini Medi, Chief Legal Officer and Secretary of Phoenix Education Partners, Inc. (NYSE:PXED), filed a Form 4 on August 27, 2026, disclosing two transactions in the company's common stock dated August 25, 2026.
Emily M. Leproust, Chief Executive Officer and Director of Twist Bioscience Corp (NASDAQ:TWST), filed a Form 4 on August 27, 2026, disclosing the sale of 41,570 shares of common stock on August 25, 2026, pursuant to a previously adopted Rule 10b5-1 trading plan.
Lindsay Drucker Mann, Global Chief Financial Officer of Oddity Tech Ltd, filed a Form 4 on August 27, 2026, reporting a cashless exercise of stock options and a same-day sale of Class A ordinary shares on August 26, 2026.
Mark Christopher Lynne, Chief Executive Officer and Director of Phoenix Education Partners, Inc. (NYSE:PXED), filed a Form 4 on August 27, 2026, reporting the exercise of employee stock options and a related share disposition on August 25, 2026.
Cheryl M. Naumann, Chief Human Resources Officer of Phoenix Education Partners, Inc. (NASDAQ:PXED), filed a Form 4 on August 27, 2026, disclosing transactions in the company's common stock dated August 26, 2026.
David Fisher, Executive Chairman of Enova International, Inc. (NYSE:ENVA), filed a Form 4 on August 27, 2026, disclosing the exercise of stock options and the subsequent sale of common shares on August 25 and August 26, 2026, pursuant to a pre-established Rule 10b5-1 trading …
A Form 4 filed on August 27, 2026, with the SEC discloses that Shachar Erez, a director of Riskified Ltd. (NYSE:RSKD), reported the sale of Class A Ordinary Shares on August 25 and August 26, 2026, executed through entities affiliated with Qumra Capital.
Abu Dhabi Investment Authority and affiliated entities filed a Form 4 on August 27, 2026, disclosing a sale of Class A Common Stock in Jersey Mike's Subs Inc. (NASDAQ:JMKE) on August 25, 2026, in connection with a partial exercise of underwriters' option to purchase …
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), filed a Form 4 on August 27, 2026, disclosing the exercise of stock options and the sale of common stock on August 26, 2026, under a pre-arranged Rule 10b5-1 trading plan.
Jonathan Skelly, President of James Hardie North America at James Hardie Industries plc (NYSE:JHX), filed a Form 4 on August 27, 2026, disclosing transactions in ordinary shares and employee stock options dated August 25, 2026.